PRESIDENT & CEO, ACADIA PHARMACEUTICALS
Stephen Davis has extensive experience leading life science companies, going all the way back to 1994 when he was president and CEO of Neurogen Corporation. Today he leads ACADIA, a pharma company that has developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease. Previously, Davis served as executive vice president and chief operating officer at Heron Therapeutics, Inc., where he still serves as a board member today.
